INVO Bioscience Inc (INVO)

[dazetrader]

INVO BIOSCIENCE $IVOB SI Increased By 2277.78%
EPS for Neogen (NEOG) Expected At $0.28;
September 7, 2018 - By Mike Johnson

INVO Bioscience, Inc. (OTCMKTS: $IVOB

Analysts expect Neogen Corporation (NASDAQ:NEOG) to report $0.28 EPS on September, 18.They anticipate $0.05 EPS change or 21.74% from last quarter’s $0.23 EPS. NEOG’s profit would be $14.51 million giving it 81.74 P/E if the $0.28 EPS is correct. After having $0.33 EPS previously, Neogen Corporation’s analysts see -15.15% EPS growth. The stock increased 0.94% or $0.85 during the last trading session, reaching $91.55. About 80,733 shares traded. Neogen Corporation (NASDAQ:NEOG) has risen 56.69% since September 7, 2017 and is uptrending. It has outperformed by 44.12% the S&P500. Some Historical NEOG News: 22/03/2018 – NEOGEN 3Q SPLIT ADJ. EPS 32C; 22/03/2018 – Neogen 3Q Rev $95.9M; 06/04/2018 – Jerome Hagedorn Named Neogen VP of Food Safety Ops; 22/03/2018 – NEOGEN CORP NEOG.O : CRAIG-HALLUM RAISES TARGET PRICE TO $65 FROM $63; RATING HOLD; 22/03/2018 – Neogen 3Q EPS 32c; 22/03/2018 – NEOGEN 3Q EPS 32C, EST. 23C; 17/05/2018 – Consolidated Research: 2018 Summary Expectations for TrueCar, Roadrunner Transportation, Eldorado Gold, Neogen, Ashford Hospita; 22/03/2018 NEOGEN 3Q REV. $95.9M, EST. $97.9M; 06/04/2018 – Hagedorn named Neogen VP of food safety operations; 20/04/2018 – DJ Neogen Corporation, Inst Holders, 1Q 2018 (NEOG)

INVO BIOSCIENCE INC (OTCMKTS:IVOB) had an increase of 2277.78% in short interest. IVOB’s SI was 85,600 shares in September as released by FINRA. Its up 2277.78% from 3,600 shares previously. With 539,200 avg volume, 0 days are for INVO BIOSCIENCE INC (OTCMKTS:IVOB)’s short sellers to cover IVOB’s short positions. The SI to INVO BIOSCIENCE INC’s float is 0.1%. The stock decreased 4.14% or $0.02 during the last trading session, reaching $0.41. About shares traded. INVO Bioscience, Inc. (OTCMKTS:IVOB) has 0.00% since September 7, 2017 and is . It has underperformed by 12.57% the S&P500.

Investors sentiment increased to 6.71 in 2018 Q1. Its up 5.22, from 1.49 in 2017Q4. It is positive, as 13 investors sold Neogen Corporation shares while 15 reduced holdings. 27 funds opened positions while 161 raised stakes. 90.94 million shares or 167.86% more from 33.95 million shares in 2017Q4 were reported. Huntington Commercial Bank owns 1,186 shares. Voya Invest Mngmt Ltd Co holds 22,314 shares or 0% of its portfolio. Thrivent Fin For Lutherans, a Minnesota-based fund reported 34,702 shares. Louisiana State Employees Retirement System reported 22,866 shares or 0.07% of all its holdings. Price T Rowe Assocs Md holds 0% or 16,029 shares. New England Private Wealth has invested 0.45% in Neogen Corporation (NASDAQ:NEOG). Raymond James And Assocs owns 4,961 shares for 0% of their portfolio. Ny State Common Retirement Fund accumulated 1.04M shares or 0.09% of the stock. Smithfield owns 46 shares or 0% of their US portfolio. The New York-based Bnp Paribas Arbitrage Sa has invested 0% in Neogen Corporation (NASDAQ:NEOG). Citadel Advisors Ltd Llc holds 206,871 shares or 0.01% of its portfolio. Millennium Mngmt holds 0% or 3,012 shares. Ny State Teachers Retirement Systems holds 52,513 shares or 0.01% of its portfolio. Cambridge Research Advsrs owns 0.02% invested in Neogen Corporation (NASDAQ:NEOG) for 28,354 shares. Creative Planning stated it has 0% of its portfolio in Neogen Corporation (NASDAQ:NEOG).

More recent Neogen Corporation (NASDAQ:NEOG) news were published by: Seekingalpha.com which released: “Neogen acquires genetic services provider for cattle breeding” on September 05, 2018. Also Streetinsider.com published the news titled: “Neogen Corp. (NEOG) to Acquire Livestock Genetic Services” on September 04, 2018. Twst.com‘s news article titled: “Derek Johnston, Portfolio Manager for Conestoga Capital, Owns Neogen (NASDAQ:NEOG), CoStar Group (NASDAQ …” with publication date: August 09, 2018 was also an interesting one.

Neogen Corporation, together with its subsidiaries, develops, makes, and markets various products for food and animal safety worldwide. The company has market cap of $4.75 billion. It operates through two divisions, Food Safety and Animal Safety. It has a 75.66 P/E ratio. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells.

Neogen Corporation (NASDAQ:NEOG) Institutional Positions Chart


https://enbulletin.com/2018/09/07/eps-for-neogen-neog-expected-at-0-28-invo-bioscience-ivob-si-increased-by-2277-78/

$IVOB